Clinical Trial Matcher

NCT05322343

Biobank and Brain Health in Bordeaux.

Recruiting · Not specified · University Hospital, Bordeaux · registry updated 2025-08-11

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general population from the age of 55 (the approximate age of onset of the first cognitive disorders and a target population particularly receptive to prevention messages). Special interest will be given to nutrition, a promising environmental exposure for prevention.

Inclusion

  • For the main study:
  • live in Bordeaux metropolitan area,
  • be between 55 and 80 years old (included),
  • selected in terms of socioeconomic level, according to a sampling strategy by age groups and income categories representative of the general population between 55 and 80 years of age
  • be affiliated with the social security system,
  • agree to take a blood sample for the biobank.

Exclusion

  • For the main study: persons under guardianship (or more generally under protection), unable to give consent to participate.
  • For the MRI sub-study: have a contraindication to MRI examination (pacemaker, a valve prosthesis or any other internal electrical/magnetic device; history of neurosurgery or aneurysm; claustrophobia; presence of metal fragments in the eyes, brain or spinal cord).

Open NCT05322343 on ClinicalTrials.govAll conditions